Limitations of currently available Chagas disease chemotherapy.

@article{Murcia2012LimitationsOC,
  title={Limitations of currently available Chagas disease chemotherapy.},
  author={L Murcia and Bartolom{\'e} Carrilero and Manuel Segovia},
  journal={Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia},
  year={2012},
  volume={25 1},
  pages={1-3}
}
1 Rev Esp Quimioter 2012;25 (1):1-3 post-treatment, which was deemed to reflect the effectiveness of the treatment to clear parasites better than serology. Moreover, PCR allowed treatment failure to be ratified – in our case in 6.9% of the patients, who shifted to positive at the end of the follow-up period. Although PCR is a sensitive and specific tool for the early detection of the parasite’s susceptibility to treatment, a negative PCR result does not necessarily indicate parasitological cure… CONTINUE READING

From This Paper

Topics from this paper.

References

Publications referenced by this paper.
Showing 1-10 of 16 references

Nifurtimoxchemotherapy: collateral effects in treated Trypanosoma cruzi infected patients

  • L Murcia, B Carrilero, M. Segovia
  • Rev Esp Quimioter
  • 2012

Similar Papers

Loading similar papers…